Funding Opportunities

submenu

Extramural grant review opportunity available

Writing a grant? Need another set of eyes?

The Masonic Cancer Center Science Council can appoint individuals to review cancer center faculty members' grant drafts* or grant ideas in a face-to-face setting or in writing, depending on the stage of grant development. The goal is to improve upon members' success in obtaining grants funded by the NCI, ACS, and other national cancer research organizations.

To request a review, contact Elizabeth Fedie, efedie@umn.edu, 624-0653.

*Members should submit their ideas or abstracts and specific aims one cycle (~3-4 months minimum) before the grant is due. We will usually provide feedback within 1 week.

News and notices


 

NOT-OD-17-002

Adjustment to Stipend Levels for Postdoctoral Trainees and Fellows on Ruth L. Kirschstein National Research Service Awards (NRSA)

The purpose of this Notice is to announce the process whereby recipients of Kirschstein-NRSA institutional training grant and individual fellowship awards supporting currently active postdoctoral trainees or fellows with 0, 1, or 2 years of experience as of December 1, 2016, will received increased stipends. The Notice also provides instructions for requesting one-time supplemental funding to cover the stipend increase.


 

NIH Proposal Preparation Program (P3)

AHC - Medical School Office of Faculty Affairs

P3 is available to early-career, assistant professor faculty members in the Academic Health Center preparing their first K- or R-series NIH grant proposal. It is a small (10-12 members), highly interactive, peer grant writing group that meets 13 times over four months. Each session requires participants to prepare drafts of their proposal sections and critique one another’s written material. Because writing begins immediately, P3 is only suitable for faculty whose project aims and approaches are reasonably well conceptualized and who are truly “ready to write.”

Key Dates: 

Applications due November 17, 2016


 

NOT-OD-17-005

Electronic Submission Method to Request Application Exceeding $500,000 Direct Costs
NIH has a longstanding policy that states any applicant requesting $500,000 or more in direct costs (excluding consortium F&A costs) in any one budget period within a competitive segment is required to contact the NIH Institute or Center (IC) Program Official (PO), in writing or by telephone, as early as possible during development of the application but no later than 6 weeks before submission for prior approval. After initial communication with the NIH, a PO may open up a request form for the Principal Investigator (PI) in eRA Commons, under a new Prior Approval Module. The PI will complete the form and submit it back to the initiating PO for review.


NOT-OD-16-147

Policy on Funding Opportunity Announcements (FOA) for Clinical Trials

NIH will require that all applications involving one or more clinical trials be submitted through a Funding Opportunity Announcement (FOA) specifically designed for clinical trials. This means that the NIH will no longer accept clinical trial applications through "parent" FOA announcements or through other FOAs that are not specifically designed to accept clinical trials. The purpose of this policy is to improve our ability to identify proposed clinical trials, ensure that key pieces of trial-specific information are submitted with each application, and uniformly apply trial-specific review criteria. NIH defines clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.


New Topic Areas for FY16: Bladder Cancer, Lymphoma, Pediatric Brain Tumors and Immunotherapy

The FY16 Defense Appropriations Act provides $50 million to the Department of Defense Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research.

The PRCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY16 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in April and July 2016. Pre-application and application deadlines will be available when the Program Announcements are released.

Learn more about this opportunity


NOT-OD-16-031

This notice informs the biomedical and health services research community of planned changes to the PHS Research Performance Progress Report (RPPR) instructions for all annual non-competing (Type 5) NIH & AHRQ awards that support research activities.

These updates to address Rigor and Transparency will take effect for RPPRs due on or after January 25, 2016.

Updates to NIH & AHRQ Research Performance Progress Reports



NOT-TR-15-020

Notice of Corrections to PAR-15-173 "Pre-Application for Collaborative Innovation Award, CTSA Program (X02)"

Learn more about this notice


Consideration of Sex as a Biological Variable in NIH-funded Research

Sex and gender play a role in how health and disease processes differ across individuals, and consideration of these factors in research studies informs the development and testing of preventive and therapeutic interventions in both sexes.  This notice focuses on NIH's expectation that scientists will account for the possible role of sex as a biological variable in vertebrate animal and human studies.

Learn more about this notice: NOT-OD-15-102

 

External funding opportunities

Postdoctoral Fellowships for Training in Cancer Research

World Health Organization

Early career scientists wishing to complete their training in those aspects of cancer research related to the Agency’s mission, are invited to apply. Disciplines covered are: epidemiology (all disciplines included), biostatistics, bioinformatics, and areas related to mechanisms of carcinogenesis including molecular and cell biology, molecular genetics, epigenetics, and molecular pathology. Interdisciplinary projects are encouraged.

Key Dates:

Full applications due November 30, 2016


The Kimmel Scholar Award

Sidney Kimmel Foundation

The Kimmel Scholar Award is given to promising young cancer researchers.  Of the 15 annual Awards, ten are typically given in the fields of basic cancer research and five for translational science.  The Program bridges the funding gap for gifted young cancer researchers at the very outset of their careers.  With the pressure to secure resources eased, Scholars are emboldened to pursue innovative, imaginative investigations and to establish their models in independent research, a necessity for obtaining government grants and other backing.

Funding:

$200,000 over two years

Key Dates:

Full application due December 1, 2016


SU2C Catalyst Research Grant: Genentech-Supported Projects

Genentech will provide funding to support several research projects of $1 to $3 million each over a three-year grant term. Applications will be evaluated by a subcommittee of the SU2C Catalyst Executive Committee.

Key Dates:

Submission deadline: December 1, 2016, 12 Noon EST


Damon Runyon Physician-Scientist Training Award

Damon Runyon Cancer Research Foundation
In an effort to confront the crisis arising from a growing dearth of physician-scientists, Damon Runyon wishes to encourage more physicians to pursue research careers. To do so, in 2014, the Foundation established a pilot program designed to recruit outstanding U.S. Specialty Board-eligible physicians (MDs only) into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their cancer clinical training.

Funding:

$460,000 over four years; in addition, the Foundation will retire up to $100,000 of any medical school debt still owed.

Key Dates: 

Thursday, December 1, 2016
Detailed information about the award, eligibility criteria, application guidelines and forms are available on the Foundation’s website. If you have any questions, please call the Foundation at 212-455-0520.


Pancreatic Cancer Action Network Translational Research Grant

Supports an independent investigator leading a cross-disciplinary team conducting translational research that has as its endpoint the development of a pancreatic cancer assessment, prevention or treatment modality

Funding:

$300,000 over 2 years

Key Dates:

Application due December 1, 2016


Request for Letters of Intent (LOI) - Scholar in Women’s Health Research

Powell Center for Women’s Health

The Powell Center Scholar in Women’s Health Research award is designed to assist a junior faculty (female or male) develop a research career focused on women’s health or sex differences research. The program will provide mentorship, training, oversight, and pilot funds. Applicants must be able to make a strong case connecting how their research impacts the health of aging women. Research projects do not have to involve studies exclusively of this group or of conditions that only affect aging women. In addition to the research project, each recipient is expected to undertake activities that will benefit the Powell Center and the field of women’s health or sex/gender differences.

Funding: $35,000 in research support for two years (total: $70,000)

Key Dates:

Letter of Intent due December 2, 2016.

Full applications due February 17, 2017


PA-16-294

NIH Support for Conferences and Scientific Meetings (Parent R13)

The purpose of the NIH Research Conference Grant (R13) is to support high quality scientific conferences that are relevant to the NIH's mission and to the public health. A conference is defined as a symposium, seminar, workshop, or any other organized and formal meeting, whether conducted face-to-face or via the internet, where individuals assemble (or meet virtually) for the primary purpose to exchange technical information and views or explore or clarify a defined subject, problem, or area of knowledge, whether or not a published report results from such meeting. The NIH recognizes the value to members of the research community and all other interested parties in supporting such forums.

Funding:
Budgets are not limited but need to reflect the actual needs of the proposed project.

Key Dates:
Full application due December 12, 2016


 

AACR-AstraZeneca Fellowship in Ovarian Cancer Research

 

The AACR-AstraZeneca Fellowship in Ovarian Cancer Research represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct ovarian cancer research and to establish a successful career path in this field. The research proposed for funding  must have direct applicability to ovarian cancer with a specific focus on DNA damage repair pathways and may be basic, translational, clinical, or epidemiological in nature. Any proposals that address  topics unrelated to DNA damage repair pathways in ovarian cancer will NOT be accepted.

 

Funding:

$110,000 2-year grant to support salary and benefits

 

Key Dates:

 

Application due December 14, 2016 at 1 p.m. EST


Brain Tumor Project RFP

Humor to Fight the Tumor

Humor to Fight the Tumor​ (HTFT)​ is one of the country’s premier fundraising events benefiting those living with brain tumors and those researching more effective treatments.  Funds raised from their 2016 fundraising event will be granted to three organizations: American Brain Tumor Association (ABTA), Mayo Clinic, and the University of Minnesota. Grants are due to HTFT by the end of the year and require internal coordination and signoff by the University of Minnesota Foundation.

Grant Guidelines

Projects must demonstrate research in the area of brain tumors. Funds cannot be used for:

  • Ongoing operational costs
  • Personal grants to individuals
  • Individual salary or salaries

Funding:

$75,000-$200,000

Key Dates:

One page summaries due December 14, 2016 at 12 Noon. Email to Rebecca Godar (godar009@umn.edu)

Summaries should be submitted in word document format (not pdf).  Summaries will be initially internally reviewed by the Brain Tumor Program Executive Committee. It is anticipated that 3-4 projects will be selected and forwarded to HTFT to be considered for funding. Investigators selected for funding by HTFT will be notified in January/February 2017 with funding available shortly thereafter.

Questions? Please contact Rebecca Godar or Ashley Schempp, john3587@umn.edu


PAR-16-457

National Cancer Institute Program Project Applications (P01)
With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of at least three research projects and an Administrative Core. The projects must share a common central theme, focus, and/or overall objective.

Funding: 

Application budgets are not limited but need to reflect the actual needs of the proposed project.  Maximum period of 5 years.

Key Dates:

December 14, 2016: Requests are due for proposals of $500,000 or more direct costs in any year.
January 25, 2017: Full application due.



2017 Epidemiology Grants

Alex’s Lemonade Stand Foundation (ALSF)

These awards will support investigators pursuing research studies in human populations using epidemiological approaches aimed at improving our understanding of childhood cancer. This grant mechanism is designed to support hypothesis-driven research that focuses on the epidemiology, early detection and prevention of childhood cancer or comparative effectiveness and outcomes research related to detection, prevention and treatment.

Funding:

$100,000 in direct costs per year for two years.

Key Dates:

Full application due December 15, 2016


PAR-17-049

NCI Research Specialist (Laboratory-based Scientist) Award (R50)

This FOA invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not serve as independent investigators. These scientists, such as researchers within a research program, are vital to sustaining the biomedical research enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others for career continuity.

Funding: Application budgets may request the following two expenses in direct costs per year:

1) salary support for the Research Specialist commensurate with their current level of funded effort (at least 6-person months) on NCI-funded research grants; and,

2) travel costs to attend research meetings/conferences not to exceed $2,500 per year

The maximum award period is 5 years.

Key Dates:

Full application due February 2, 2017

 


RFA-CA-16-016

Population-based Research to Optimize the Screening Process (PROSPR) (UM1)
The overall goal for PROSPR Research Centers is to enhance understanding of the implementation and effects of screening as practiced in multiple, heterogeneous healthcare environments in the United States. Therefore, the research programs proposed must cover long-term observations of diverse cohorts of patients who are eligible for screening. In addition to observational research to evaluate factors that affect the quality of the screening process for the selected cancer type, these programs should also develop and pilot-test interventions aimed at improving the screening process for that cancer.
It is expected that this FOA will support one PROSPR Research Center for each of the three cancer types: cervical, colorectal, and lung cancer. Each proposed Research Center must be entirely focused on screening for one of these three eligible cancer types.
In addition, PROSPR Research Centers to be proposed must be able to study the cancer screening processes in at least three different healthcare systems. Therefore, appropriate collaborative arrangements with providers of screening/diagnostic services are required.

Funding:

A maximum of $2.5 million in direct costs for any budget year. A project period of 5 years must be proposed.

Key Dates:

Letter of Intent due January 9, 2017
Full application due February 9, 2017


 

PAR-16-457

National Cancer Institute Program Project Applications (P01)

With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of at least three research projects and an Administrative Core. The projects must share a common central theme, focus, and/or overall objective.

Funding:

Application budgets are not limited but need to reflect the actual needs of the proposed project.

The maximum project period is 5 years.

Key Dates:

Full application due January 25, 2017


Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54)

NIH/NCI

This Funding Opportunity Announcement (FOA) invites cooperative agreement (U54) applications for the implementation of Comprehensive Partnerships between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI-designated Cancer Centers (CC). The purpose of this limited competition funding opportunity announcement (FOA) is to continue fostering and supporting intensive collaborations among investigators at ISUPS and CCs in order to develop stronger national cancer programs aimed at understanding the reasons behind the significant cancer disparities and related impacts on these populations. This FOA is intended for: (1) supporting active Comprehensive Partnerships under the U54 mechanism or inactive Comprehensive Partnerships but formerly supported by the U54 mechanism; and (2) elevating the promising U56 partnerships and other similar partnerships to the comprehensive status.

Funding:

Applications are limited to $2.5 million Direct costs per year for dyads and $3.0 million Direct cost per year for triads

The maximum period is 5 years.

Key Dates:

Full application due January 28, 2017


 

PAR-17-049

NCI Research Specialist (Laboratory-based Scientist) Award (R50)

This FOA invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not serve as independent investigators. These scientists, such as researchers within a research program, are vital to sustaining the biomedical research enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others for career continuity.

Funding:

Application budgets may request the following two expenses in direct costs per year:

1) salary support for the Research Specialist commensurate with their current level of funded effort (at least 6-person months) on NCI-funded research grants; and,

2) travel costs to attend research meetings/conferences not to exceed $2,500 per year

The maximum award period is 5 years.

Key Dates:

Full application due February 2, 2017


PAR-17-050

NCI Research Specialist (Core-based Scientist) Award (R50)

This FOA invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research.  This FOA is specifically for core/shared resource/central scientific support scientists.

The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not serve as independent investigators.  These scientists, such as researchers within a core/shared resource/central scientific support, are vital to sustaining the biomedical research enterprise.  The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others for career continuity.

Funding:

Application budgets may request the following two expenses in direct costs per year:

1) salary support for the Research Specialist commensurate with their current level of funded effort (at least 6-person months) on NCI-funded research grants; and,

2) travel costs to attend research meetings/conferences not to exceed $2,500 per year

The maximum award period is 5 years.

Key Dates:

Full application due February 2, 2017


PA-16-012

Examination of Survivorship Care Planning Efficacy and Impact (R01)
The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research evaluating the effect of care planning on self-management of late effects of cancer therapy; adherence to medications, cancer screening, and health behavior guidelines; utilization of follow-up care; survivors' health and psychosocial outcomes.

Funding: 

Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.

Key Dates:

Full application due February 5, 2017


RFA-CA-16-017

Coordinating Center for Population-based Research to Optimize the Screening Process (PROSPR)(U24)
The overall goal for the PROSPR Research Centers is to enhance understanding of the implementation and effects of screening as practiced in multiple healthcare environments in the United States. The intent of this FOA is to fund a single Coordinating Center that will support a network of three PROSPR Research Centers (PRCs; one each focused on cervical, colorectal, and lung cancer). Specifically, the Coordinating Center will facilitate the development of common measures across cancer types for (1) system-level factors that may impact the cancer screening process, and (2) quality of screening. It will also coordinate PROSPR network research projects that include more than one cancer type. Finally, the Coordinating Center will be responsible for developing and implementing a process for PROSPR data access and sharing with qualified investigators outside of the PROSPR network.

Funding:

$1,000,000 in direct costs per year.  A project period of 5 years must be proposed.

Key Dates:

Full application due February 9, 2017


PAR-16-176

NCI Clinical and Translational Exploratory/Developmental Studies (R21)

This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies--including the use of new clinically-relevant models and imaging technologies--which could lead to first-in-human clinical trials.

Funding:

The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Key Dates:

Full application due February 21, 2017


RFA-CA-17-010

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)

This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology.

Funding:

$400,000 Direct Costs over a 3-year period, with no more than $200,000 allowed in any single year.

Key Dates:

Full application due February 28, 2017


RFA-CA-17-011

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)

This FOA solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community.

Funding:

$300,000 Direct Costs per year for a maximum of 3 years.

Key Dates:

Full application due February 28, 2017


RFA-CA-17-012

Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)

This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses.

Funding:

Direct costs are limited to $400,000 over a 3-year period, with no more than $200,000 in direct costs allowed in any single year.

Key Dates:

Full application due February 28, 2017


RFA-CA-17-013

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)

This FOA solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses.

Funding:

Direct costs are limited to $300,000 per year for a maximum of 3 years.

Key Dates:

Full application due February 28, 2017


BD Biosciences Cancer Research Grant

A total of $100,000 worth of research reagents are awarded annually to 10 scientists. Through the grant program, BD Biosciences supports scientists pursuing innovative ideas in cancer research, helping to define the next generation of scientific breakthroughs.

Funding:

$100,000 in research reagents

Key dates:

Full Application due April 1, 2017


Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)

(NOT-OD-15-044)
(PAR-15-075)
National Cancer Institute

Funding:

Standard R01 limits apply

Application Receipt Date(s):

Standard dates apply, by 5:00 PM local time of applicant organization.


NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

(PAR-15-064)
National Cancer Institute

Funding:

$100,000/yr towards salary; $30,000/yr for other expenses

Application Receipt Date(s):

Multiple dates, see announcement.


NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)

(PAR-15-062)
National Cancer Institute

Application Receipt Date(s):
Multiple dates, see announcement.

Funding:

$100,000/yr towards salary; $30,000/yr for other expenses


National Cancer Institute Program Project Applications (P01)

(PAR-15-023)
National Cancer Institute

Application Receipt Date(s):
Multiple dates, see announcement.

Funding:
Varies. 


Advancing Interventions to Improve Medication Adherence

PA-14-334 – R01 and PA-14-335 – R21

National Cancer Institute

Application Receipt Date(s):

Multiple dates, see announcement.

Funding:

Standard R01 & R21 limit


Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)

(PAR-14-242)
National Cancer Institute

Application Receipt Date(s):  

See announcement for dates.

Funding:

Standard R01 limits apply 


Interventions for Health Promotion and Disease Prevention in Native American Populations (R01)

(PAR-14-260)
National Cancer Institute

Application Receipt Date(s):

See announcement for dates.

Funding:

Standard R01 limits apply.


Genomic Resource Grants for Community Resource Projects (U41)

(PAR-14-191)
National Cancer Institute

Funding:

5 years of funding.  Application budgets are not limited, but should reflect the needs of the proposed project.

Application Receipt Date(s):

January 25, 2017


Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)

(PA-14-114)
National Cancer Institute

Funding:

Standard R01 limits apply.

Application Receipt Date(s):

Multiple dates, see announcement.


Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)

(PAR-14-013)
National Cancer Institute

Funding:

Standard R21 limits apply

Deadline:

See announcement for dates.


Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01)

(PAR-14-116)
National Cancer Institute

Funding:

$500,000/yr for 5 years

Application Receipt Date(s):

Multiple dates, see announcement 


Modeling Social Behavior (R01)

(PAR-13-374)
National Cancer Institute

Funding:

Standard R01 limits apply

Deadline:

Multiple dates, see announcement.


Research to Characterize and Reduce Stigma to Improve Health

R01 (PA-13-248), R03 (PA-13-247) and R21 (PA-13-246)

National Cancer Institute

Funding:

Standard limits apply.

Application Receipt Date(s):

Multiple dates, see announcement.  Standard cycle dates.


Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness

R01 (PA-13-165), R15 (PA-13-166) and R21 (PA-13-167)

National Cancer Institute

Funding:

Standard limits apply. See announcements for additional information

Application Receipt Date(s):

Multiple dates, see announcement.


Bioengineering Research Grants (BRG) (R01)

(PAR-13-137)
National Cancer Institute

Funding:

Standard R01 limits apply.

Application Deadline: 

Multiple receipt dates, see announcement.


Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01)

(PAR-13-169)
National Cancer Institute

Funding:

Standard R01 limits apply

Application Receipt Date(s):

Multiple dates, see announcement.


 

Funding resources

Federal agencies funding cancer-related research

Search funding opportunities; sign up to receive the NIH Guide weekly via e-mail.

Search for funding sources by keyword; sign up for e-mail notification of funding opportunities. (Note: NIH listings are under DHHS, the Department of Health and Human Services.)

Non-federal agencies funding cancer-related research

Research funding directories

CFDA is a database of all federal programs available to state and local governments; federally recognized Indian tribal governments; territories (and possessions) of the United States; domestic public, quasi-public, and private profit and nonprofit organizations and institutions; specialized groups; and individuals.

This funding opportunity search engine provides the world's most comprehensive funding resource, with more than 24,000 records representing nearly 400,000 opportunities ranging from local non-profit funding to federally funded grants.

This is a sortable database of current funding opportunities pulled from various databases. It boasts a user-friendly interface and a comprehensive listing. While the listing is not as comprehensive as other databases in this list, opportunities may be easier to find in this abbreviated format.

(requires x.500 login)

The premier grantseeking database on the Web, developed by the Foundation Center, a national nonprofit service organization founded over 50 years ago to open up U.S. foundations to public view.

A fee-based service, to which the University of Minnesota is a current subscriber. It currently contains over 9,000 active federal and private funding opportunities in the sciences, social sciences, arts, and humanities. In addition to funding opportunities for faculty, the GrantForward Database also contains fellowships and scholarships for grad students and undergrads. Users can search  by sponsor, deadline date, keyword, and other criteria. Most GrantForward records contain live links to sponsor Web sites, electronic forms, or Electronic Research Administration (eRA) portals. The database is updated daily.

InfoEd's SPIN is the most widely used funding opportunity database in the world. By aggregating sponsor information in one system, SPIN dramatically cuts search times and substantially increases the likelihood of positive results. Program information is presented in a standard format that allows investigators to readily compare opportunities. This search engine is great for post-doctoral associates looking for funding opportunities.